查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997396

高通量筛检市场：按产品类型、技术、板规格、应用和最终用户分類的全球市场预测，2026-2032年

High-Throughput Screening Market by Product Type, Technology, Plate Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，高通量筛检市场价值将达到 223.2 亿美元，到 2026 年将成长至 232.4 亿美元，到 2032 年将达到 334.4 亿美元，复合年增长率为 5.94%。

主要市场统计数据
基准年 2025 223.2亿美元
预计年份：2026年 232.4亿美元
预测年份 2032 334.4亿美元
复合年增长率 (%) 5.94%

先进的高通量筛检时代已经到来，它透过优先考虑检测准确性、自动化柔软性和数据完整性来加速药物发现流程。

高通量筛检(HTS) 已从一项小众自动化技术发展成为现代药物发现和转化研究的基础，使研究机构能够以前所未有的规模快速分析化学空间和生物表型。如今，实验室中的 HTS 工作流程整合了先进的检测系统、自动化液体处理和资料管理平台，从而缩短了从目标识别到先导化合物筛选的时间。随着各机构寻求加速研发流程并降低失败率，筛检能力的评估标准不仅包括通量，还包括柔软性、检测准确性以及有助于后续决策的数据品质。

技术、进阶分析和服务模式的整合正在重塑筛检工作流程，以实现更高的准确性和转化相关性。

高通量定序（HTS）领域正经历一场变革，其驱动力包括技术的成熟、研发模式的转变以及对更高资料品质的需求。微流体和晶片实验室技术的进步显着降低了试剂消耗，使得以往难以大规模的单细胞检测和微型化检测变得更加可行。无标定检测方法与成像和高内涵分析相结合，能够产生兼具表型复杂性和高通量分析能力的混合结果。这些技术进步得益于液体处理精度和微孔板形式的改进，使得在不影响结果重复性的前提下，能够使用较小的样本量进行更多类型的检测。

关税驱动的采购系统重组和加强供应链韧性的措施正在重新定义筛检作业中的供应商选择、采购和平台决策。

美国已实施和提案于2025年实施的关税措施对高通量定序（HTS）生态系统内的筹资策略、供应链韧性和成本结构提出了重大考量。对某些类别的设备和进口实验室耗材征收的关税迫使采购团队重新评估筹资策略，在满足特定产品性能需求的同时，权衡跨境交易带来的财务和物流影响。因此，各组织更重视供应商多元化、与本地经销商建立合作关係，并预留更长的前置作业时间，以降低关税相关延误和价格波动带来的风险。

横断面細項分析揭示了产品、技术、版面、应用和最终用户趋势如何相互作用并影响采用和价值实现。

细分市场洞察揭示了不同的需求驱动因素和技术组合，这些因素指南产品开发和商业化策略。在产品类型细分中，耗材（例如专用实验室设备、试剂和检测试剂盒）对于检测性能至关重要，并且通常决定检测结果的可重复性；而仪器（包括检测和液体处理系统）则决定了检测通量和准确度的上限。涵盖检测开发、验证和筛检的服务使企业能够在无需大量资本投入的情况下利用客製化功能，而涵盖化合物管理和数据分析的软体产品对于将原始筛检结果转化为可操作的候选化合物谱至关重要。这些产品层面的动态造成了相互依​​赖关係，耗材的最佳化、仪器相容性和软体工作流程的最佳化共同决定了端到端检测的成功。

美洲、欧洲、中东和非洲以及亚太地区的创新生态系统和监管环境的细微差异，正在推动针对特定区域的采用和伙伴关係策略。

高通量筛检(HTS) 领域的区域趋势受到美洲、欧洲、中东和非洲以及亚太地区独特的创新生态系统、监管环境和商业基础设施的影响。在美洲，强大的製药和生物技术公司丛集，以及先进的学术研究网络，共同支持对尖端设备和综合服务的需求。对转化研究的投入以及众多受託研究机构(CRO) 的存在，产生了协同效应，加速了技术应用和合作筛检计划的发展。

供应商的整合策略，结合模组化设备、可靠的耗材、检验的服务和先进的分析，是其在竞争格局中脱颖而出的关键因素。

高通量筛选（HTS）生态系统中的主要企业致力于打造整合的价值提案，将硬体效能、耗材可靠性、服务专长和先进软体功能融为一体。仪器製造商正在扩展其模组化产品线，以支援高密度筛检和复杂的表型分析。他们优先考虑跨平台的互通性和改造升级，从而能够在不进行设备更换的情况下升级现有工作流程。试剂和实验室设备供应商认识到，试剂性能直接影响筛选结果的重现性和下游检验的成功率，因此正在投资改进配方和品管，以减少批间差异并提高检测间的一致性。

为了赢得新员工，领导者需要采取切实可行的策略措施来推动互通性、在地支援、严格检验和灵活的经营模式。

随着高通量定序 (HTS) 的发展，产业领导者应优先考虑互通性、可復现性和策略伙伴关係伙伴关係，以获取价值。投资于平台模组化和升级路径可以减轻采用者的负担，并维护与现有客户的关係，使他们能够在不完全更换系统的情况下扩展功能。同样，为耗材建立健全的品管标准和透明的检验通讯协定，可以赢得研发部门采购负责人的信任，因为他们需要跨站点和研究实验室的可复现性。透过将产品蓝图与最终用户的工作流程和相容性要求相匹配，供应商可以降低采用门槛并提高客户终身价值。

透过严格结合专家访谈、技术文献综述和交叉检验，我们对筛检技术、工作流程和采购趋势提供了平衡的见解。

本报告整合了第一手和第二手调查的调查方法，旨在提供关于高通量检测（HTS）趋势的平衡且基于实证的观点。第一手调查包括对设备製造商、耗材供应商、软体供应商、服务供应商、学术研究人员和采购负责人等领域的意见领袖进行深入访谈，以深入了解HTS的采用驱动因素、挑战和策略重点。这些访谈旨在了解实际决策标准，并检验在该领域观察到的新兴趋势。

综合解决方案、注重可重复性以及共同采购是将高通量筛检的进步转化为一致的药物发现结果的策略基础。

高通量筛检正处于转折点，技术进步、供应链现状和不断演进的研发模式相互交织，迫使企业重新调整策略重点。微流体技术、晶片实验室和无标定检测技术的成熟，拓展了可大规模运作的检测范围。同时，液体处理和微孔板形式的改进，使得工作流程更有效率且可重复。同时，关税趋势加剧了采购压力，区域能力建构的需求也要求企业制定更精细的采购和伙伴关係策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：高通量筛检市场：依产品类型划分

  • 消耗品
    • 实验室设备
    • 试剂和检测试剂盒
  • 装置
    • 检测系统
    • 液体处理系统
  • 服务
    • 检测方法开发与验证
    • 筛检
  • 软体
    • 化合物管理
    • 数据分析

第九章：高通量筛检市场：依技术划分

  • 基于细胞的检测
    • 萤光成像盘式分析仪仪检测
    • 基于报告基因的检测
  • 晶片实验室技术（LOC）
  • 无标定技术
  • 基于微流体技术的

第十章：以板型分類的高通量筛检市场

  • 1536孔盘
  • 384孔盘
  • 96孔盘

第十一章：高通量筛检市场：依应用划分

  • 药物发现
  • 基因组学和蛋白​​质组学
  • 分子筛检
  • 毒理学和安全性评估

第十二章 高通量筛检市场：依最终使用者划分

  • 学术和研究机构
  • 合约研究机构
  • 医院/诊断检查室
  • 製药和生物技术公司

第十三章：高通量筛检市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：高通量筛检市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：高通量筛检市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国高通量筛检市场

第十七章：中国的高通量筛检市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomat Srl
  • BMG LABTECH GmbH
  • BRAND GMBH+CO KG
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Creative Biolabs, Inc.
  • Danaher Corporation
  • DIANA Biotechnologies, as
  • Eppendorf SE
  • EUROFINS SCIENTIFIC SE
  • Gilson Company, Inc.
  • Hamilton Company
  • HighRes BioSolutions, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Mettler Toledo International, Inc.
  • PerkinElmer, Inc.
  • Revvity, Inc.
  • Sartorius AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-501246436FA8

The High-Throughput Screening Market was valued at USD 22.32 billion in 2025 and is projected to grow to USD 23.24 billion in 2026, with a CAGR of 5.94%, reaching USD 33.44 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 22.32 billion
Estimated Year [2026] USD 23.24 billion
Forecast Year [2032] USD 33.44 billion
CAGR (%) 5.94%

An evolved high-throughput screening era emphasizing assay fidelity, automation flexibility, and data integrity to accelerate discovery pipelines

High-throughput screening (HTS) has evolved from a niche automation capability into a cornerstone of contemporary drug discovery and translational research, enabling institutions to rapidly interrogate chemical space and biological phenotypes at unprecedented scale. Across laboratories, HTS workflows now integrate advanced detection systems, automated liquid handling, and data management platforms that together compress timelines from target identification to lead selection. As organizations seek to accelerate pipelines and reduce attrition, screening capabilities are increasingly judged not only on throughput but on flexibility, assay fidelity, and the quality of the data that informs downstream decisions.

The convergence of consumables innovation, instrument sophistication, service models, and analytical software has broadened the value proposition of HTS beyond simple large-scale testing. Consumables such as specialized labware and reagent kits are engineered to optimize assay robustness, while detection and liquid handling platforms are being designed to support miniaturized plate formats and complex cell-based readouts. Meanwhile, service providers offering assay development, validation, and end-to-end screening enable organizations without in-house capacity to leverage HTS capabilities rapidly, and software tools for compound management and data analysis are essential to manage the volume and complexity of screening outputs.

Taken together, these dynamics are reshaping priorities for R&D leaders, who now prioritize assay scalability, data integrity, and cross-platform interoperability. This report synthesizes the key technological, regulatory, and commercial drivers that are defining HTS strategy and capability development across academic, clinical, and industrial settings, offering a clear roadmap for decision-makers aiming to translate screening investments into measurable therapeutic and discovery outcomes.

Technological convergence, advanced analytics, and service models are reshaping screening workflows toward higher fidelity and translational relevance

The HTS landscape is undergoing transformative shifts driven by technological maturation, changing R&D models, and the imperative for enhanced data quality. Advances in microfluidics and lab-on-a-chip technologies are enabling dramatic reductions in reagent consumption and facilitating single-cell and miniaturized assays that were previously impractical at scale. Label-free detection modalities are converging with imaging and high-content approaches, creating hybrid readouts that capture phenotypic complexity while preserving throughput. These technological progressions are supported by improvements in liquid handling precision and plate formats, which together allow a broader array of assay types to be executed in smaller volumes without sacrificing reproducibility.

Alongside instrumentation, software and data analytics have shifted from peripheral tools to central pillars of HTS workflows. Compound management systems that integrate with screening platforms now ensure sample traceability and reduce error, while advanced data analysis pipelines-incorporating machine learning and pattern recognition-enhance hit identification and triage. The rise of contract research organizations and service-based screening models has also changed adoption patterns, enabling organizations to access specialized assays and validation services without capital-intensive investments. These shifts encourage portfolio-level experimentation and support adaptive R&D strategies.

Regulatory and quality expectations are simultaneously tightening, prompting suppliers to emphasize assay validation, documentation, and reproducibility. As a result, decision-makers increasingly favor integrated solutions that deliver robustness across consumables, instruments, services, and software. This confluence of developments is redefining what constitutes competitive advantage in HTS, placing a premium on interoperability, translational relevance, and the ability to generate high-confidence data that accelerates downstream development.

Tariff-driven procurement restructuring and supply chain resilience measures are redefining vendor selection, sourcing, and platform decisions in screening operations

United States tariff measures enacted and proposed for 2025 have introduced material considerations for procurement strategies, supply chain resilience, and cost structures within HTS ecosystems. Tariffs on certain categories of instrumentation and imported laboratory consumables have driven procurement teams to reassess sourcing strategies, balancing the need for specific product performance against the financial and logistical implications of cross-border transactions. As a result, organizations have placed greater emphasis on vendor diversification, local distributor relationships, and longer lead-time planning to mitigate exposure to tariff-related delays and price volatility.

In response to tariff pressures, some institutions have increased collaboration with domestic manufacturers and service providers to hedge against supply chain disruptions. This has accelerated interest in modular platforms that can be upgraded or serviced locally, and heightened scrutiny of suppliers' end-to-end sourcing maps. Procurement professionals are also evaluating total cost of ownership more rigorously, factoring in not only initial purchase price but also maintenance, consumable compatibility, and the potential for tariff-driven cost fluctuations.

Moreover, tariffs have spurred innovation in procurement strategies, including pooled purchasing across academic consortia and the use of contract research partnerships to obtain specialized capabilities without transferring capital expense. These adaptations maintain scientific momentum while managing financial impact. Looking ahead, the interplay between trade policy and strategic sourcing will continue to influence vendor selection, platform standardization, and the geography of HTS capability development.

Cross-cutting segmentation analysis reveals how product, technology, plate format, application, and end-user dynamics interact to shape adoption and value realization

Segmentation insights reveal differentiated demand drivers and technology pairings that inform product development and commercialization strategies. Within product type segmentation, consumables such as specialized labware and reagents and assay kits are critical to assay performance and are often the differentiator in reproducibility, while instruments comprising detection systems and liquid handling systems set the ceiling for throughput and precision. Services that encompass assay development and validation as well as screening create pathways for organizations to access bespoke capabilities without heavy capital outlay, and software offerings covering compound management and data analysis are essential to convert raw screening outputs into actionable candidate profiles. These product-level dynamics create interdependencies where consumable optimization, instrument compatibility, and software workflows collectively determine end-to-end assay success.

Technology segmentation highlights the growing prominence of cell-based assays, including fluorometric imaging plate reader assays and reporter-based assays, which are favored for their biological relevance. Parallel advances in lab-on-a-chip and microfluidics based approaches support miniaturized, higher-content assays that reduce reagent use and enable novel experimental designs, while label-free technologies offer complementary kinetic and mechanistic insights. Choices in plate format segmentation-ranging from high-density 1536-well plates to 384-well and 96-well formats-reflect trade-offs between throughput, data quality, and assay complexity, with higher-density plates suitable for large compound libraries and lower-density formats preferred for complex or primary-cell assays.

Application segmentation underscores that drug discovery, genomics and proteomics, molecular screening, and toxicology and safety assessment each impose distinct requirements on throughput, data fidelity, and assay design. End user segmentation shows that academic and research institutes, contract research organizations, hospitals and diagnostic labs, and pharmaceutical and biotechnology companies have diverse priorities tied to budget cycles, regulatory needs, and timelines. Understanding these segmentation layers enables vendors and purchasers to align product roadmaps, service offerings, and support models with the nuanced demands of each user cohort.

Regional innovation ecosystems and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific drive differentiated adoption and partnership strategies

Regional dynamics in the HTS landscape are shaped by distinct innovation ecosystems, regulatory environments, and commercial infrastructures across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong pharmaceutical and biotech clusters, coupled with advanced academic research networks, sustain demand for both cutting-edge instrumentation and comprehensive service offerings. Investment in translational research and a large base of contract research organizations create synergies that accelerate technology adoption and collaborative screening projects.

Europe, the Middle East & Africa present a heterogeneous picture where regulatory rigor and strong academic institutions drive high standards for assay validation and data quality. Local manufacturing capabilities in certain European countries support resilient supply chains, and collaborative research initiatives across borders foster technology transfer and standardization efforts. In markets across the Middle East and Africa, concentrated investments in diagnostic capacity and regional centers of excellence are gradually expanding the base of sophisticated screening users.

Asia-Pacific is characterized by rapid capacity expansion, substantial investments in biotech and pharmaceutical manufacturing, and growing internal demand for both instruments and consumables. Domestic suppliers in several Asia-Pacific countries are increasingly competitive on price and are improving on quality, prompting multinational vendors to adapt their regional strategies. Across all regions, cross-border collaboration and knowledge exchange are driving harmonization of best practices, even as local regulatory and procurement nuances continue to influence adoption pathways and partnership structures.

Integrated vendor strategies combining modular instruments, reliable consumables, validated services, and advanced analytics are defining competitive differentiation

Leading companies across the HTS ecosystem are focusing on integrated value propositions that combine hardware performance, consumable reliability, service expertise, and advanced software capabilities. Instrument manufacturers are expanding modular portfolios to support both high-density screening and complex phenotypic assays, prioritizing platform interoperability and retrofitability so that existing workflows can be upgraded without disruptive capital replacement. Suppliers of reagents and labware are investing in formulation improvements and quality control to reduce batch variability and enhance inter-assay consistency, recognizing that reagent performance directly influences hit reproducibility and downstream validation success.

Service providers are differentiating through deep assay development expertise, regulatory-grade validation processes, and flexible engagement models that range from standalone campaigns to long-term partnerships. Software vendors are embedding analytics, visualization, and machine learning into compound management and data analysis solutions, enabling more rapid hit triage and richer biological interpretation. Across the competitive landscape, strategic collaborations and distribution partnerships are common as companies seek to assemble comprehensive solutions that address enterprise pain points related to throughput, data integrity, and cross-platform compatibility.

Companies that demonstrate responsiveness to procurement pressures-such as local support infrastructure and total cost of ownership transparency-tend to gain traction with institutional buyers. Those that invest in partnerships with academic centers and CROs to validate translational relevance of their platforms build credibility among translational researchers and commercial developers. Overall, the most successful firms balance technological leadership with service excellence and pragmatic deployment models to maximize adoption across diverse end users.

Practical strategic moves for leaders to advance interoperability, regional support, validation rigor, and flexible commercial models to win adoption

Industry leaders should prioritize interoperability, reproducibility, and strategic partnerships to capture value as HTS evolves. Investments in platform modularity and upgrade pathways reduce friction for adopters and protect installed-base relationships, enabling customers to expand capabilities without wholesale replacement. Similarly, establishing robust quality control standards for consumables and transparent validation protocols builds trust with R&D buyers who demand reproducibility across sites and studies. By aligning product roadmaps with end-user workflows and compatibility requirements, suppliers can lower barriers to adoption and increase lifetime customer value.

Building regional service footprints and trusted distributor networks mitigates procurement risks and counters tariff-induced supply chain pressures. Collaborations with academic centers and CROs can accelerate real-world validation, broaden addressable use cases, and create referral pathways into long-term commercial relationships. On the software side, embedding analytics and machine learning into compound management and data analysis reduces time-to-insight and enhances decision-making across hit selection and lead optimization. Firms should also offer flexible commercial models, including service subscriptions and outcome-aligned contracts, to meet the evolving budgetary preferences of academic, clinical, and industrial buyers.

Finally, leaders should adopt transparent total cost of ownership messaging and provide robust post-sale support, training, and validation services. These measures not only improve customer satisfaction but also protect revenue streams by reinforcing the value of integrated hardware, consumables, services, and software in delivering high-confidence screening outcomes.

A rigorous blend of expert interviews, technical literature review, and cross-validation delivers balanced insights into screening technologies, workflows, and sourcing dynamics

This report synthesizes primary and secondary research methodologies to ensure a balanced and evidence-based perspective on HTS dynamics. Primary research comprised in-depth interviews with thought leaders across instrument manufacturing, consumables supply, software vendors, service providers, academic researchers, and procurement professionals, providing qualitative insights into adoption drivers, pain points, and strategic priorities. These conversations were conducted to capture real-world decision criteria and to validate emerging trends observed in the field.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, technical specifications, product white papers, and conference proceedings to contextualize technological developments and validate performance claims. Comparative analysis of platform capabilities, assay types, and end-user requirements informed segmentation logic and allowed the synthesis of cross-cutting themes. Triangulation of primary and secondary inputs ensured robust interpretation of supply chain implications, tariff impacts, and regional adoption patterns.

Throughout the research process, special attention was given to reproducibility metrics, assay validation practices, and data management approaches to reflect the factors that most influence practical adoption. Limitations and uncertainties were acknowledged where proprietary performance data were unavailable, and recommendations are framed to be actionable within the bounds of accessible evidence.

Integrated solutions, reproducibility focus, and collaborative sourcing form the strategic foundation for turning high-throughput screening advances into consistent discovery outcomes

High-throughput screening stands at an inflection point where technological advances, supply chain realities, and evolving R&D models intersect to reshape strategic priorities. The maturation of microfluidics, lab-on-a-chip, and label-free detection is expanding the repertoire of assays that can be executed at scale, while improvements in liquid handling and plate formats enable more efficient and reproducible workflows. At the same time, procurement pressures-exacerbated by tariff dynamics-and regional capability building necessitate more sophisticated sourcing and partnership strategies.

For stakeholders across academic, clinical, and industrial settings, the path forward emphasizes integrated solutions that pair robust consumables and adaptable instruments with validated services and advanced analytics. Such approaches reduce operational risk, increase the translational relevance of screening outputs, and accelerate decision-making in lead discovery and safety assessment. Strategic collaboration, regional support infrastructure, and transparent validation practices will be critical in converting technological potential into consistent scientific outcomes.

In summary, organizations that prioritize interoperability, data quality, and flexible engagement models will be best positioned to harness the current wave of HTS innovation and translate screening investments into sustainable discovery performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High-Throughput Screening Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Labware
    • 8.1.2. Reagents & Assay Kits
  • 8.2. Instruments
    • 8.2.1. Detection Systems
    • 8.2.2. Liquid Handling Systems
  • 8.3. Services
    • 8.3.1. Assay Development & Validation
    • 8.3.2. Screening
  • 8.4. Software
    • 8.4.1. Compound Management
    • 8.4.2. Data Analysis

9. High-Throughput Screening Market, by Technology

  • 9.1. Cell-Based Assays
    • 9.1.1. Fluorometric Imaging Plate Reader Assays
    • 9.1.2. Reporter based Assays
  • 9.2. Lab-on-a-chip Technology (LOC)
  • 9.3. Label-free Technology
  • 9.4. Microfluidics Based

10. High-Throughput Screening Market, by Plate Format

  • 10.1. 1536-well plate
  • 10.2. 384-well plate
  • 10.3. 96-well plate

11. High-Throughput Screening Market, by Application

  • 11.1. Drug Discovery
  • 11.2. Genomics & Proteomics
  • 11.3. Molecular Screening
  • 11.4. Toxicology & Safety Assessment

12. High-Throughput Screening Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Diagnostic Labs
  • 12.4. Pharmaceutical & Biotechnology Companies

13. High-Throughput Screening Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. High-Throughput Screening Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. High-Throughput Screening Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States High-Throughput Screening Market

17. China High-Throughput Screening Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Aurora Biomed, Inc.
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Biomat S.r.l
  • 18.9. BMG LABTECH GmbH
  • 18.10. BRAND GMBH + CO KG
  • 18.11. Charles River Laboratories International, Inc.
  • 18.12. Corning Incorporated
  • 18.13. Creative Biolabs, Inc.
  • 18.14. Danaher Corporation
  • 18.15. DIANA Biotechnologies, a.s
  • 18.16. Eppendorf SE
  • 18.17. EUROFINS SCIENTIFIC SE
  • 18.18. Gilson Company, Inc.
  • 18.19. Hamilton Company
  • 18.20. HighRes BioSolutions, Inc.
  • 18.21. Lonza Group AG
  • 18.22. Merck KGaA
  • 18.23. Mettler Toledo International, Inc.
  • 18.24. PerkinElmer, Inc.
  • 18.25. Revvity, Inc.
  • 18.26. Sartorius AG
  • 18.27. Tecan Trading AG
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 209. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 236. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 242. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 247. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 253. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)